Instil Bio, Inc. (TIL)
NASDAQ: TIL · Real-Time Price · USD
24.15
+0.79 (3.38%)
Nov 21, 2024, 11:52 AM EST - Market open
Instil Bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 158 | 50 | 82 | 2,206 | - | - |
| Market Cap Growth | 686.44% | -39.38% | -96.29% | - | - | - |
| Enterprise Value | 89 | -48 | -151 | 1,691 | - | - |
| Last Close Price | 23.36 | 7.62 | 12.60 | 342.20 | - | - |
| PB Ratio | 0.78 | 0.22 | 0.22 | 3.97 | - | - |
| P/TBV Ratio | 2.25 | 0.22 | 0.22 | 4.09 | - | - |
| Debt / Equity Ratio | 0.44 | 0.38 | 0.22 | - | - | - |
| Asset Turnover | - | - | - | - | 0.00 | - |
| Quick Ratio | - | 14.34 | 8.02 | 10.98 | 18.20 | 6.26 |
| Current Ratio | - | 15.22 | 8.22 | 11.22 | 18.53 | 6.54 |
| Return on Equity (ROE) | - | -52.96% | -48.58% | -37.00% | -25.12% | - |
| Return on Assets (ROA) | - | -14.01% | -23.60% | -20.89% | -12.11% | - |
| Return on Capital (ROIC) | -14.73% | -14.98% | -25.80% | -22.90% | -13.24% | - |
| Earnings Yield | -49.31% | -314.94% | -272.97% | -7.11% | - | - |
| FCF Yield | -207.21% | -323.82% | -8.16% | - | - |
| Buyback Yield / Dilution | -0.05% | -0.44% | -22.19% | -562.55% | -62.05% | - |
| Total Shareholder Return | -0.05% | -0.44% | -22.19% | -562.55% | -62.05% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.